Docetaxel Plus Carboplatin and Trastuzumab in Patients With Metastatic HER2-Positive Breast Cancer: 20-Year Follow-Up
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer
Oncologist 2023 Nov 02;28(11)e1123-e1126, JL Gomez Marti, A Nasrazadani, Y Ding, D Normolle, AM BrufskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.